Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

Heinemann, L, Simpson, GR, Boxall, A et al. (8 more authors) (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC Cancer, 11 (1). ARTN 221. ISSN 1471-2407

Abstract

Metadata

Authors/Creators:
  • Heinemann, L
  • Simpson, GR
  • Boxall, A
  • Kottke, T
  • Relph, KL
  • Vile, R
  • Melcher, A
  • Prestwich, R
  • Harrington, KJ
  • Morgan, R
  • Pandha, HS
Copyright, Publisher and Additional Information: © Heinemann et al; licensee BioMed Central Ltd. 2011 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Paclitaxel; Docetaxel; Combination Index; Oncolytic Virus; Delay Tumour Growth
Dates:
  • Published: 6 June 2011
  • Accepted: 6 June 2011
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Biomarkers and Therapy (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Oncology and Cancer Research - Labs (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 07 Mar 2019 15:43
Last Modified: 07 Mar 2019 15:43
Status: Published
Identification Number: https://doi.org/10.1186/1471-2407-11-221

Share / Export

Statistics